4//SEC Filing
Doyle Anthony 4
Accession 0001127602-20-015179
CIK 0000882796other
Filed
May 3, 8:00 PM ET
Accepted
May 4, 4:08 PM ET
Size
5.3 KB
Accession
0001127602-20-015179
Insider Transaction Report
Form 4
Doyle Anthony
Chief Financial Officer
Transactions
- Award
Emp. Stock Option (Right to Buy)
2020-04-30+600,000→ 600,000 totalExercise: $3.91From: 2021-04-30Exp: 2020-04-30→ Common Stock (600,000 underlying)
Footnotes (1)
- [F1]Initial Employee Option Grant, 200,000 of which become exercisable on the first anniversary of the grant date or upon termination if, within the first year of his employment, Mr. Doyle is impacted by a reduction in force at the Company, and the remainder of which will vest in three equal installments on the second, third and fourth anniversaries of the grant date.
Documents
Issuer
BIOCRYST PHARMACEUTICALS INC
CIK 0000882796
Entity typeother
Related Parties
1- filerCIK 0001808688
Filing Metadata
- Form type
- 4
- Filed
- May 3, 8:00 PM ET
- Accepted
- May 4, 4:08 PM ET
- Size
- 5.3 KB